ClinicalTrials.govpublic full text
Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
hiv infections, immune tolerance, interleukin-2, drug therapy, combination, aids-related complex, zidovudine, cd4-positive t-lymphocytes, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853513
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.